US Government Received $400 Million in COVID-19 Vaccine Royalty Payments: Moderna

US Government Received $400 Million in COVID-19 Vaccine Royalty Payments: Moderna
Moderna's headquarters in Cambridge, Mass., on May 8, 2020. Maddie Meyer/Getty Images
Zachary Stieber
Updated:
0:00

Moderna said on Feb. 23 that it recently reached a patent agreement with the U.S. government over disputed technology that is featured in its COVID-19 vaccine.

In December 2022, Moderna entered “a nonexclusive patent license agreement” with the National Institute of Allergy and Infectious Diseases (NIAID), said CFO Jamey Mock during an earnings call on Thursday.

Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics